Regedent Italia and Thommen Medical Italia forge partnership to revolutionize regenerative therapies in oral surgery
Vicenza, 5th November 2024
Regedent Italia is proud to announce a strategic partnership with Thommen Medical Italia, with the goal of offering innovative regenerative therapies that reduce the need for invasive surgery and improve the predictability of Guided Bone Regeneration (GBR) treatments.
Thommen Medical Italia’s activities will allow it to contribute to activities and experiences that will add to the scientific evidence supporting CLEAN&SEAL therapy , a revolutionary treatment for the management of peri-implantitis and severe periodontitis. CLEAN&SEAL combines two cutting-edge products:
- PERISOLV an additional cleaning agent used to detoxify infected implant surfaces and surrounding tissues.
- hyaDENT BG, a high-molecular-weight, cross-linked hyaluronic acid gel that regenerates both hard and soft tissues.
In addition to CLEAN&SEAL there will be a proposal of Regedent’s experience with the **smartGBR** solution, designed to accelerate wound healing and improve bone regeneration in oral surgery. smartGBR integrates the use of hyaDENT BG gel with resorbable membranes (**SMARTBRANE**) and advanced bone substitutes (**SMARTGRAFT**) that increase the rate of new bone formation while enhancing angiogenesis, leading to faster wound closure and optimal patient outcomes.
The joint promotion of **CLEAN&SEAL** and **smartGBR** is aimed at realizing useful experiences toward advancing dental regeneration and creating a healthier future for patients.This partnership will enable both companies to offer practitioners innovative and scientifically supported treatment options for complex dental cases.
Thommen Medical Italia S.r.l.
Maurizio Rosa, General Manager
maurizio.rosa@thommenmedical.com